Moderna has withdrawn its application to approve the influenza-Covid-19 combination vaccine, intending to resubmit the application with additional data later
Miruna Brosban
Health
sursa foto: pexels.com
Always see our news on Google
The decision follows consultations with the FDA, which has requested new clinical trials for Covid-19 booster doses. Moderna shares fell 1.4% amid declining revenue from Covid-19 vaccines and concerns about the nomination of Robert F. Kennedy Jr. to be secretary of the Health Department. The FDA is expected to decide on the next-generation Covid-19 vaccine, part of the combination vaccine, with no anticipated delays.
Sources
Latest News
13:39
Hundreds of reservists from Neamț, Suceava and Botoșani are taking part in MOBEX 2026, including live-fire exercises at the Gârleni Training Range
13:30
Anamaria Gavrilă: POT will support a “technocratic” government appointed by Nicușor Dan
13:17
„Fjord”, nominated for the Oscars, will have its national premiere on January 15, 2027
13:05
Mountain rescuers from Hunedoara rescued a German tourist injured in the Retezat Mountains
12:56
The leader of the parliamentary group of national minorities, Varujan Pambuccian, asked President Nicușor Dan to postpone the appointment of the prime minister
See more news
NEWS ON THE SAME TOPICS
.webp)
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
